GE HealthCare Announces FES PET Imaging Recommendation in NC

NCCN Guidelines® for clinicians and patients now recommend the use of FES PET for ER+ positive disease under certain circumstances during the systemic staging workup of patients with recurrent... | May 24, 2023

Related Keywords

University Of Washington , Washington , United States , Seattle , Hannahm Linden , David Mankoff , Mark Hibberd , Society Of Nuclear Medicine , Zionexa Us Corp , Facebook , Ge Healthcare Company , Fred Hutchinson Cancer Center , Linkedin , University Of Pennsylvania , Twitter , Ge Healthcare , Patient Care Solutions , Ge Healthcare Technologies Inc , Nuclear Medicine , Molecular Imaging , Appropriate Use Criteria , Practice Guidelines , Business Wire , Vice Chair , Breast Medical Oncologist , Chief Medical Officer , Pharmaceutical Diagnostics , Care Technologies , Tumor Characterization , Clinical Trials , Endocrine Therapies , Target Estrogen , Nucl Med , Metastatic Breast Cancer From , Estrogen Receptor Expression , Bone Dominant Breast Cancer , Shows Return , Ge Healthcare Technologies Inc Stock Exchange , News , Information , Press Release , Nccn , Or , Clinicians , End , Patients , Dow , Recommend , The , Tse , F , Yes , Pet , Positive , Disease , Under , Certain , Circumstances , During , Systemic , Staging , Workup , Ith Gehc Us36266g1076 ,